Business Standard

Chinese Covid-19 vaccine found 79% effective in late stage trial

A Chinese inactivated vaccine shows 79.34 percent efficacy against Covid-19, according to the interim results of the phase-3 clinical trials

Coronavirus, vaccine, covid, drugs, clinical trials

Representational image of a Covid-19 vaccine

IANS Beijing

A Chinese inactivated vaccine shows 79.34 percent efficacy against COVID-19, according to the interim results of the phase-3 clinical trials unveiled by its developer on Wednesday.

The inactivated vaccine has been developed by the Beijing Biological Products Institute Co., Ltd. under the China National Biotec Group (CNBG), which is affiliated to Sinopharm, Xinhua news agency reported.

After a two-dose inoculation procedure, the vaccine receivers all produced high titers of antibodies, and the seroconversion rate of neutralising antibodies reached 99.52 percent.

The results meet the requirements of technical standards of the World Health Organization and the standards stipulated by China's National Medical Products Administration (NMPA).

 

The company has submitted an application to the Chinese regulator for conditional market approval.

--IANS

gb/bg

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Dec 30 2020 | 6:24 PM IST

Explore News